We had revenue in the quarter approaching a rolling 12-month revenue of over 7.6 billion, and an adjusted EBIT margin for the same period of 4.2%, which was in line with the rolling 12-month number in Q1. Let's take a look at the numbers in more detail. We had revenues exceeding 2 billion in the quarter. As mentioned, we had a stable growth of 10.9%. We had a slightly higher growth rate in Rx. But we had stable growth in both OTC and traded goods, as well as in Rx. Rx continued to increase its share of the revenues in the quarter. To the right, you can see our gross margin development. And we had a stable gross margin in the quarter. We had a strong profitability in the quarter. We increased adjusted EBIT to 105 million SEK, despite increased depreciation of more than 17 million kronor. And we had an adjusted EBIT margin of 5.2%. If you look to the right, you can see our selected operating costs as a percentage of revenue. And as expected, the depreciation and amortization increased. And that is the result of the fulfillment center in Varberg, which was established last year. At the same time, we have improved efficiency. As you can see, there is a decline in personnel and other external expenses as a percentage of revenue. The improved efficiency is the result of continued good cost control. But we also get better cost leverage as we increase capacity utilization. If you look at the year-to-date figures, we had a stable growth of 10.7% for the first half of the year. Also looking at the first half year, Rx grew slightly higher than OTC and traded goods and increased its share of revenues. Adjusted EBIT increased to 206 million SEK, and we had stable profitability. And that corresponds to an adjusted EBIT margin of 5.2%. And also for the first half year, we have also seen a high increase. As expected, depreciation and amortization for the first half year increased by roughly 35 million SEK. We had lower operating cash flow in Q2 as well as year-to-date. The operating cash flow was impacted by inventory. And the inventory has increased in part due to inventory buildup in Varberg, but also temporary measures to ensure robustness in the supply chain, as we have highlighted before. To the right, you can see our CapEx; following the completion of the fulfilment centre in Varberg, we have had a significantly lower investment pace in the half-year. We have very limited investments, and as we now are scaling up the production in Varberg, we are at the same time evaluating and figuring out what new investments are best suited for these operations. Investments are likely to remain low this year. However, if you look at the longer period between investments related to new fulfilment centres, we are still expecting a yearly average of CapEx of 50 to 70 million SEK. We had inventory of slightly above 850 million SEK at the end of June. Over the course of the last year, we have increased inventory, mainly due to the buildup of inventory in Varberg, and as a consequence of the increased inventory, inventory turnover has also declined. We expect to gradually increase the inventory turnover as capacity utilization increases, but also by further optimization. Let's take a look at the return on capital employed. We have a high return on capital employed of over 27 percent, although it has declined over the past year as a result of the fulfillment centre in Varberg, and to the right, you can see our net debt and net cash position. At the end of June, we continued to have a very strong balance sheet and a cash position of 104 million. And this is despite an increased inventory and also dividend paid out in Q2 of roughly 62 million SEK.